Evidence map›Paper›PMID 26657146›Full record

ArticleScientific reports2015

Increased Variability of Genomic Transcription in Schizophrenia.

Fuquan Zhang, Yin Yao Shugart, Weihua Yue, Zaohuo Cheng, Guoqiang Wang, Zhenhe Zhou, Chunhui Jin, Jianmin Yuan, Sha Liu, Yong Xu

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fuquan ZhangWuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China.
Yin Yao ShugartUnit on Statistical Genomics, Division of Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America.
Weihua YueInstitute of Mental Health, Sixth Hospital, Peking University; Beijing 100191, China.
Zaohuo ChengWuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China.
Guoqiang WangWuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China.
Zhenhe ZhouWuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China.
Chunhui JinWuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China.
Jianmin YuanWuxi Mental Health Center, Nanjing Medical University, Wuxi, Jiangsu Province, China.
Sha LiuDepartment of Psychiatry, First Hospital /First Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Yong XuDepartment of Psychiatry, First Hospital /First Clinical Medical College of Shanxi Medical University, Taiyuan, China.

Funding

Developing new statisical methods to detect variants involved in complex diseaseZIAMH002929 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI YAO, YIN · 2011 to 2016
$2.6M
NIMH NIH HHS MH002929-04
6 · The paper itself

Abstract

Schizophrenia (SZ) is a severe chronic mental disorder with a high heritability. Current microarray analyses typically focus on identifying differentially expressed genes or enriched pathways relevant to phenotypes. Whether there is a variability change of the genomic transcription in diseases has rarely been explored. In this study, we compared coefficient of variation (CV, the ratio of the standard deviation to the mean) of genome transcription of early-onset SZ (EOS) patients with controls in a blood mRNA microarray dataset and a blood microRNA (miRNA) microarray dataset. Furthermore, we compared CV of the expression levels of 17 genes in blood of the 30 patients before and after the 12-week treatment using real-time quantitative PCR (RT-qPCR) analysis. Our results indicated a significant increase of CV of genome transcription in patients compared with controls in both the mRNA and the miRNA datasets. The 30 after-treatment patients showed a significant decrease of CV of gene expression compared with the before-treatment patients. Our study may implicate the blood gene expression variability in SZ, providing further evidence supporting the abnormality of peripheral blood transcriptome in SZ. Given that peripheral blood can be easily collected from patients and followed longitudinally, our results may indicate a new way to facilitate the identification of the signatures of clinical subtypes, their prognosis and treatment response.

Indexed as

Gene Expression RegulationGenetic VariationTranscription, GeneticAdultCase-Control StudiesFemaleGene Expression ProfilingGenomicsHumansMaleMicroRNAsMiddle AgedRNA, MessengerSchizophreniaTranscriptomeYoung AdultMicroRNAsRNA, Messenger

Identifiers

PMID26657146
PMCPMC4675071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.